Anti-Tumor Pazopanib Hydrochloride 99% API Powder Pazopanib HCl

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of US$ 25/g
Request Sample
Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Management System Certification
ISO 9001, ISO 14001, GMP, HACCP
  • Anti-Tumor Pazopanib Hydrochloride 99% API Powder Pazopanib HCl
  • Anti-Tumor Pazopanib Hydrochloride 99% API Powder Pazopanib HCl
  • Anti-Tumor Pazopanib Hydrochloride 99% API Powder Pazopanib HCl
  • Anti-Tumor Pazopanib Hydrochloride 99% API Powder Pazopanib HCl
  • Anti-Tumor Pazopanib Hydrochloride 99% API Powder Pazopanib HCl
  • Anti-Tumor Pazopanib Hydrochloride 99% API Powder Pazopanib HCl
Find Similar Products
  • Overview
  • Product Description
  • Product Datails
  • Application&Function
  • Specification
Overview

Basic Info.

Model NO.
D-Sung Pazopanib Hydrochloride
Product Name
Pazopanib Hydrochloride
Name
Pazopanib HCl Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
99%
Application
Pharmaceutical
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
635702-64-6
Mf
C21h23n7o2s.Clh
MW
473.987
Boiling Point
>290c
Einecs
619-728-0
Transport Package
Negotiable
Specification
Negotiable
Trademark
D-sung
Origin
Shaanxi Xi′an
Production Capacity
500kg/Month

Product Description

Anti-Tumor Pazopanib Hydrochloride 99% API Powder Pazopanib HCl
Anti-Tumor Pazopanib Hydrochloride 99% API Powder Pazopanib HCL
Product Description

 

Anti-Tumor Pazopanib Hydrochloride 99% API Powder Pazopanib HClAnti-Tumor Pazopanib Hydrochloride 99% API Powder Pazopanib HCl
Product Datails

 

Anti-Tumor Pazopanib Hydrochloride 99% API Powder Pazopanib HCl
Product name Pazopanib
Cas number 635702-64-6
Apperance White Powder
Boiling Point 290°
MF C21H23N7O2S.ClH
MW 473.987
Pazopanib is researched and developed by a GlaxoSmithKline ,it is a novel oral vascular generation inhibitor which may interfere stubborn tumor survival and new blood vessels generation growth needed .Targeting vascular endothelial receptor (VEGFR),it works by inhibiting angiogenesis of tumor blood supply.      it is suitable for advanced renal cell carcinoma ( a discovery of cancer cells in the renal tubules), soft tissue sarcoma (STS), epithelial ovarian cancer and non-small cell lung cancer (NSCLC) treatment.
Application&Function

 

Anti-Tumor Pazopanib Hydrochloride 99% API Powder Pazopanib HClPazopanib Hydrochloride is the hydrochloride salt of a small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity.         Pazopanib selectively inhibits vascular endothelial receptors (VEGFR)-1, -2 and -3, c-kit and platelet derived  receptor (PDGF-R), which may result in inhibition of angiogenesis in tumors in which these receptors are upregulated.
Pazopanib Indications:
1.    FDA-approved for patients with advanced kidney cancer.
2.    FDA-approved for patients with advanced soft tissue sarcoma (STS) who have previously received chemotherapy.
Specification

 

Anti-Tumor Pazopanib Hydrochloride 99% API Powder Pazopanib HCl
Anti-Tumor Pazopanib Hydrochloride 99% API Powder Pazopanib HCl
Anti-Tumor Pazopanib Hydrochloride 99% API Powder Pazopanib HClAnti-Tumor Pazopanib Hydrochloride 99% API Powder Pazopanib HClAnti-Tumor Pazopanib Hydrochloride 99% API Powder Pazopanib HClAnti-Tumor Pazopanib Hydrochloride 99% API Powder Pazopanib HClAnti-Tumor Pazopanib Hydrochloride 99% API Powder Pazopanib HCl

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier